Jobs / United States / Pfizer INC
Oncology RWE/Epi Scientist, Senior Manager
Pfizer INC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Pfizer INC paid sponsored hires in similar roles3 certified filings for “SENIOR SCIENTIST” (Biochemists and Biophysicists) in CT: $120k–$128k, median $128k. Most were filed at wage level I (100%) — 1 lottery entry, ≈15% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
Role Summary The Senior Manager, Oncology, position within the Medical Evidence Development (MED), Integrated Evidence Generation (IEG) organization, Real-World Evidence & Epidemiology (RWE/Epi) provides an opportunity for a collaborative epidemiologist to support real-world evidence and epidemiologic studies as part of Medical strategy across the entire drug development process. The candidate will be responsible for synthesizing the literature and contributing to the design, conduct and reporting of global epidemiologic research studies on Pfizer Oncology pipeline assets and approved products. The Senior Manager will also be accountable for the quality, timeliness, and efficiency of all RWE/Epi deliverables in assigned product/disease area, and maintain an internal network of Pfizer stakeholders to cultivate innovation, cross-functional collaboration, and identify new opportunities for RWE/Epi to increase the value of Pfizer assets. The candidate will develop external partnerships to leverage data resources and collaboration on high priority global studies. Responsibilities include authoring and reviewing study protocols, reports, and presentations, as well as communication in writing and presentations to internal stakeholders, regulatory authorities, and medical professionals. The candidate will also be responsible for non-study deliverables such as RWE insights, epidemiology literature reviews, regulatory responses, and department initiatives. This position will report directly to the Oncology Team Lead in RWE/Epi. Capabilities • Skill and experience identifying, designing and supporting or leading real-world evidence studies of disease epidemiology and effectiveness as part of the global cross-functional Integrated Evidence Plan. • Maintain knowledge and awareness of internal and external data resources and identify appropriate studies for addressing questions of interest, recognizing the limitations and strengths of various design options and data sources • Partner with Chief Medical Office colleagues to address asset team evidence needs and support global regulatory submissions to the FDA, EMA and other agencies. • Deliver rapid insights from real-world, observational data source • Develop and deliver presentations, webinars, manuscripts, scientific data packages or other communication modalities • Assure the highest standards of quality, compliance and management of all research activities • Participate in RWE/Epi peer review of study protocols and study reports • Document all requests and track progress toward project completion, other metrics and business goals Qualifications • PhD in Epidemiology, Statistics/Biostatistics, Health Outcomes Research, Quantitative Methods, Public Health, Health Economics, or Other Biological Science fields with a substantial quantitative component and at least 1 years of relevant experience in the pharmaceutical, academic and/or medical environment; or, MPH or another relevant Master’s degree and at least 5 years of experience in the pharmaceutical, academic and/or medical environment, at least 1 of which were in the pharmaceutical industry. • Demonstrated strong quantitative skills and methods expertise to generate rapid insights from real-world / observational data source • Demonstrated strong technical writing skills and oral presentation skills with a track-record of publishing in peer-reviewed journals and presenting at medical/scientific conferences • Demonstrated ability to convert complex analysis into meaningful insights with data visualization and presentation tools and able to manipulate and analyze complex structured and unstructured data from multiple real world evidence sources. • Ability to work under pressure with a high level of aut